Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYTARABINE vs GEMCITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYTARABINE vs GEMCITABINE: Safety Overview

Metric CYTARABINE GEMCITABINE
Total FAERS Reports 44,383 31,328
Deaths Reported 9,089 5,142
Death Rate 20.5% 16.4%
Hospitalizations 17,861 12,268
Average Patient Age 38.0 yrs 61.2 yrs
% Female Patients 41.2% 48.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 11, 2016
Manufacturer Sagent Pharmaceuticals Hikma Pharmaceuticals USA Inc.
Route INTRATHECAL INTRAVENOUS
Marketing Status Discontinued Discontinued